Gerald delivers the goods! We've got the LP-002 sensitivity of 94%!!! Not only did he deliver the numbers, but AMBS has executed a one-year, exclusive option agreement with Georgetown University to enter into a license for the patent rights related to certain blood based biomarkers for memory loss that Georgetown University and University of Rochester jointly own. In addition AMBS has it has acquired DioGenix, Inc. DioGenix will be merged into Amarantus Diagnostics as a foundational asset of a growing neuro-diagnostic business.MSPrecise is a lab-developed test, and the successful completion of the validation study paves the way for this clinically important test to be commercialized in 2015.